CMR Surgical Stock
CMR Surgical is developing the next-generation surgical robotic system for minimal access surgery.
Sign up today and learn more about CMR Surgical Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About CMR Surgical Stock
CMR Surgical is to make minimal access surgery available to all. With Versius they have delivered a next-generation tool to fit seamlessly into today’s operating rooms, working in harmony with the surgeon to improve patient outcomes and deliver value for healthcare providers.
Investors
Ally Bridge Group
LGT group
Funding History
| July 2016 | $20.3M |
|---|---|
| September 2017 | $26.0M |
| June 2018 | $74.0M |
| September 2019 | $240M |
| June 2021 | $425M |
Management
Chief Executive Officer
Per Vegard Nerseth
Head of Supply Chain
Jon Pebody
Chief Customer Success Officer
Paul Roberts
Board Member
Robert Tansley
Chief Medical Officer
Mark Slack
Board Chairman
Erik Langaker
Technology Director
Luke Hares
Press
globenewswire - Mar, 21 2024
CMR Surgical announces over 20,000 surgical cases completed using Versiuscambridgeindependent - Feb, 11 2024
Record quarter for CMR Surgical as installations of Versius robot soar around the worldmassdevice - Feb, 11 2024
CMR Surgical reports record surgical robot installations to end 2023, plans 2024 product launchesglobenewswire - Feb, 8 2024
A clearer vision for surgical robotics: CMR Surgical announces significant update to Versiusmassdevice - Jan, 19 2024
Viseon launches visualization system for spine surgeryEquityZen Recognized As:
